Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-26 Sale | 2021-11-16 3:09 pm | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 278 | $7.9 | $2,196 | 2,490 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-14 Option Award | 2023-03-16 4:27 pm | N/A 2033-03-14 | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2022-09-13 Option Award | 2022-09-15 4:45 pm | N/A 2032-09-13 | SAB Biotherapeutics Inc. | SABS | Beyer Russell P CHIEF FINANCIAL OFFICER | 274,875 | $0 | 274,875 (Direct) | View |
| 2022-03-16 Option Award | 2022-03-18 9:15 pm | N/A 2032-03-16 | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 6,000 | $0 | 6,000 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-19 4:45 pm | N/A 2031-11-17 | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-11-16 3:09 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 5 | $10.07 | 2,490 (Indirect) | View |
| 2021-09-28 Option Award | 2021-11-16 3:09 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 159 | $10.08 | 2,490 (Indirect) | View |
| 2021-10-18 Option Award | 2021-11-16 3:09 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 2,475 | $10.1 | 2,490 (Direct) | View |
| 2021-10-25 Option Award | 2021-11-16 3:09 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Beyer Russell P Chief Financial Officer | 129 | $7.78 | 2,490 (Indirect) | View |
Ownership | 2021-10-22 9:22 pm | N/A N/A | Big Cypress Acquisition Corp. | SABS | Beyer Russell P Chief Financial Officer | 0 | $0 | 2,475 (Direct) | View |